Sunday, January 19, 2025

Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation (Forbes)

Forbes:
Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation  —  Surbhi Sarna sold her last startup, nVision Medical, for $275 million.  Now she's leaving a partner role at Y Combinator to launch Collate …



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Apple CFO Kevan Parekh tells a London court it is impossible to accurately determine the App Store's standalone profitability and disputes claims of 75% margins (Financial Times)

Financial Times : Apple CFO Kevan Parekh tells a London court it is impossible to accurately determine the App Store's standalone pro...